Table 3.
Event | Range |
---|---|
≥6 ARTIs/y | 0.50–0.80 |
6–10 ARTIs/y | 0.80–0.90 |
11–12 ARTIs/y | 0.10–0.20 |
6 ARTIs/y | 0.05–0.10 |
7 ARTIs/y | 0.36–0.44 |
8 ARTIs/y | 0.30–0.50 |
9 ARTIs/y | 0.36–0.44 |
10 ARTIs/y | 0.05–0.10 |
11 ARTIs/y | 0.40–0.60 |
12 ARTIs/y | 0.40–0.60 |
ARTIs in Fall-Winter Season | 0.60–0.70 |
Simple acute lower ARTIs | 0.01–0.02 |
Simple acute upper ARTIs | 0.70–0.80 |
Acute otitis media | 0.13–0.25 |
Acute rhinosinusitis | 0.03–0.07 |
Tx with antibiotics for simple acute lower ARTIs | 1 |
Tx without antibiotics for simple acute upper ARTIs | 0.30–0.40 |
Tx with antibiotics for simple acute upper ARTIs | 0.60–0.70 |
Tx without antibiotics for acute otitis media | 0.20–0.30 |
Tx with antibiotics for acute otitis media | 0.70–0.80 |
Tx without antibiotics for acute rhinosinusitis | 0.10–0.20 |
Tx with antibiotics for acute rhinosinusitis | 0.80–0.90 |
Cost of Tx without antibiotics ($MXN) | 95–1450 |
Cost of Tx with antibiotics ($MXN) | 157–2491 |
Cost of parent job absenteeism ($MXN) | 630–2100 |
OM-85 effectiveness (ARTI reduction) | 0.38–0.55 |
Cost of OM-85 ($MXN) | 258–430 |
Cost of OM-85 adverse events ($MXN) | 11.1–22.2 |
Values are frequencies, unless otherwise indicated. ARTI acute respiratory tract infection, Tx treatment